Found: 12
Select item for more details and to access through your institution.
Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients with pancreatic cancer: a retrospective cohort study.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08136-0
- By:
- Publication type:
- Article
Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients with pancreatic cancer: a retrospective cohort study.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 11, p. 1, doi. 10.1007/s00520-023-08136-0
- By:
- Publication type:
- Article
Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.
- Published in:
- Supportive Care in Cancer, 2020, v. 28, n. 12, p. 5943, doi. 10.1007/s00520-020-05443-8
- By:
- Publication type:
- Article
Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unresectable Advanced Pancreatic Cancer.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5895, doi. 10.3390/jcm11195895
- By:
- Publication type:
- Article
CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00359-5
- By:
- Publication type:
- Article
Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40780-022-00239-w
- By:
- Publication type:
- Article
Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy — a retrospective observational study.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40780-021-00210-1
- By:
- Publication type:
- Article
Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy.
- Published in:
- Cancers, 2018, v. 10, n. 11, p. 454, doi. 10.3390/cancers10110454
- By:
- Publication type:
- Article
Comparison of breakthrough Gram‐positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 6, p. 1342, doi. 10.1111/jcpt.13215
- By:
- Publication type:
- Article
Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2019, v. 44, n. 6, p. 888, doi. 10.1111/jcpt.13011
- By:
- Publication type:
- Article
Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi‐institutional randomized controlled trial.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 6, p. 1462, doi. 10.1002/ijc.33316
- By:
- Publication type:
- Article
High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article